CLASS III Drug recall · Reported 16 Dec 2015 · FDA Enforcement Report

Meclizine Hydrochloride Tablets, 12.5 mg recalled

Golden State Medical Supply is recalling Meclizine Hydrochloride Tablets, 12.5 mg, distributed nationwide in the US. The recall was initiated on 25 Nov 2015 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot # GS007205 Expiry: Aug-17; Lot #:GS007344, Expiry: Aug-17; Lot #: GS008089, Expiry: Feb-18; Lot #: GS008842, Expiry: Feb-18; Lot #: GS009055, Expiry: Feb-18; Lot #: GS009131; Expiry: Feb-18.
Quantity recalled1136 Bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0509-2016
FDA event ID
72733
Recalling firm
Golden State Medical Supply, Camarillo, CA
Classification
Class III
Status
Terminated
Recall initiated
25 Nov 2015
FDA classified
4 Dec 2015
Reported
16 Dec 2015
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Potency & Assay

Timeline

25 Nov 2015Recall initiated by company
4 Dec 2015Classified by FDA+9 days
16 Dec 2015Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Impurities/Degradation Specifications: Out of specification for impurities.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

MECLIZINE HYDROCHLORIDE TABLETS, 12.5 mg, Packaged in 1000 ct Bottles, Rx Only. Manufactured by: Par Pharmaceuticals Companies Inc., Spring Valley, NY 10977. Packaged by: GSMS Incorporated, Carmarillo, CA 93012. NDC: 60429-204-10.

Where it was distributed

U.S. Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Failed Impurities/Degradation Specifications: Out of specification for impurities.

Which lots are affected?

Lot # GS007205 Expiry: Aug-17; Lot #:GS007344, Expiry: Aug-17; Lot #: GS008089, Expiry: Feb-18; Lot #: GS008842, Expiry: Feb-18; Lot #: GS009055, Expiry: Feb-18; Lot #: GS009131; Expiry: Feb-18.

Where was it sold?

U.S. Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 72733

This product is part of a recall event; the main page for the event is Meclizine Hydrochloride Tablets, 25 mg recalled.

ReportedClassRecallCompanyReasonWhere
CLASS IIIMeclizine Hydrochloride Tablets, 25 mg recalledGolden State Medical SupplyPotency & AssayNationwide

More recalls from Golden State Medical Supply

All 55

Other Meclizine recalls

All 12